NoV VP1

NoV VP1

NoV VP1 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Vindesine sulfateCompound-112531ApprovedEli Lilly And CompanyEldisineUnited KingdomLymphoma; Melanoma; Breast Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung; LeukemiaEli Lilly And Company1979-01-01
Leukemia; Esophageal Neoplasms; Small Cell Lung Carcinoma; Breast Neoplasms; Lymphoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma
Details